Panbela Therapeutics SMA 50
Was ist das SMA 50 von Panbela Therapeutics?
SMA 50 von Panbela Therapeutics Inc. ist $0 -11.64%
Was ist die Definition von SMA 50?
SMA 50 ist ein durchschnittlicher Aktienkurs der letzten 50 Tage, berechnet als ungewichteter Mittelwert der 50 letzten Schlusskurse.
Simple moving average of 50 days for a stock is an unweighted moving average over the past 50 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 50 von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Panbela Therapeutics
Was macht Panbela Therapeutics?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Unternehmen mit sma 50 ähnlich Panbela Therapeutics
- Greenstone Capital hat SMA 50 von CAD$0 -500.00%
- Mastrad Société Anonyme hat SMA 50 von $0 +0.61%
- Applied Genetic Technologies Corp hat SMA 50 von $0 +0.00%
- Pacifico Minerals hat SMA 50 von AUD$0 +99.70%
- Dxi Capital Corp hat SMA 50 von $0 +98.70%
- Summa Silver hat SMA 50 von CAD$0 -10.05%
- Panbela Therapeutics hat SMA 50 von $0 -11.64%
- Elate hat SMA 50 von HKD$0 +11.10%
- QUHUO Ltd hat SMA 50 von $0 +76.29%
- Doubleview Gold Corp hat SMA 50 von CAD$0 -4.34%
- Changmao Biochemical Engineering hat SMA 50 von HKD$0 +14.81%
- Artini hat SMA 50 von HKD$0 -7.49%
- Beijing Media hat SMA 50 von HKD$0 -2.01%